JRPIM
ABBV icon

Journey Retirement Planning & Investment Management’s AbbVie ABBV Stock Holding History

Journey Retirement Planning & Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
4,013
-109
-3% -$23.5K 0.79% 27
2026
Q1 		$897K Sell
4,122
-12,514
-75% -$2.78M 0.79% 34
2025
Q4 		$3.8M Buy
+16,636
New +$3.79M 0.78% 27

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Journey Retirement Planning & Investment Management's ABBV Position: Q2 2026 in Review

Journey Retirement Planning & Investment Management reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $23.5K and leaving 4,013 shares worth $1.01M. The position accounts for 0.79% of the portfolio, ranked #27.

Journey Retirement Planning & Investment Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.8M in Q4 2025. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Journey Retirement Planning & Investment Management held 4,013 shares of AbbVie worth $1.01M as of Q2 2026.
  • Journey Retirement Planning & Investment Management sold 109 AbbVie shares in Q2 2026, an estimated $23.5K.
  • AbbVie made up 0.79% of Journey Retirement Planning & Investment Management's portfolio in Q2 2026, its #27 holding.
  • Journey Retirement Planning & Investment Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Journey Retirement Planning & Investment Management's AbbVie position peaked at $3.8M in Q4 2025.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Journey Retirement Planning & Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.